Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

AstraZeneca (AZNL)

Add To Portfolio

13,722.00p

Change Today:

-0.56p
52 Week High: 14,156.00
52 Week Low: 9,642.00

Currency: UK Pounds
Shares Issued: 1,264.16m
Volume: 217,204

Market Cap: £173,468m

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

6 Month Chart

More AstraZeneca charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	1.7%
Div Cover	2.6
Op Mrgn	18.5%
ROCE	60.7%

	Latest	F'cast
P/E	22.5
PEG	1.7
Pr/Revenue	4.3
Pr/Book	5.7

	Latest	F'cast
Revenue	18.0%
PBT	26.0%
EPS	13.1%
DPS	6.9%

AstraZeneca Fundamentals

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	26,617.00	3,916.00	244.00¢	40.6	0.3	+137%	280.00¢	2.8%
31-Dec-21	37,417.00	(265.00)	8.00¢	1,460.7	n/a	-97%	287.00¢	2.5%
31-Dec-22	44,351.00	2,501.00	212.00¢	71.6	0.0	+2,550%	290.00¢	1.9%
31-Dec-23	45,811.00	6,899.00	726.00¢	19.7	0.1	+242%	290.00¢	2.0%
31-Dec-24	54,073.00	8,691.00	821.00¢	17.2	1.3	+13%	310.00¢	2.2%

AstraZeneca Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-25	58,484.61	18,425.84	666.91p	20.5	2.3	+9%	242.06p	0.0%
31-Dec-26	62,026.02	20,681.85	754.41p	18.1	1.4	+13%	254.90p	0.0%
31-Dec-27	65,628.95	22,834.02	840.92p	16.3	1.4	+12%	265.58p	0.0%

AstraZeneca forecasts

AstraZeneca Company Announcements

Director/PDMR Shareholding	22-Dec-2025	11:00	RNS
Enhertu granted BTD for post-neoadjuvant early BC	22-Dec-2025	07:30	RNS
Update on LATIFY Phase III trial of ceralasertib	22-Dec-2025	07:00	RNS

More astrazeneca company announcements

AstraZeneca ShareCast News

Director/PDMR Shareholding	22-Dec-2025	ShareCast
Enhertu granted BTD for post-neoadjuvant early BC	22-Dec-2025	ShareCast
Update on LATIFY Phase III trial of ceralasertib	22-Dec-2025	ShareCast

More AstraZeneca ShareCast news

AstraZeneca Top Newspaper Links

AstraZeneca CEO’s family invested in ‘major part...	10-Dec-2025	Times
Fighting Frenchman shows us how as he ensures As...	30-Dec-2014	Daily Mail
Exclusive: UK firms vie for share of £170bn in A...	08-Dec-2014	The Independent

Latest AstraZeneca Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

AstraZeneca Market Data

Currency	UK Pounds
Share Price	13,722.00p
Change Today	-0.56p
% Change	-0.41 %
52 Week High	14,156.00
52 Week Low	9,642.00
Volume	217,204
Shares Issued	1,264.16m
Market Cap	£173,468m